Nurse Practitioner, Family · El Paso, TX
NPI
1386287332
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1201 E Schuster Ave Ste 1a
El Paso, TX, 79902
Phone (915) 229-6448
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.5M
1,305 prescriptions
Company payments, 2025
$755
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jhoana P Quezada prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 168 prescriptions and refills. In total Jhoana P Quezada wrote 1,305 Medicare prescriptions that cost $2.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 168 | 168 | 33 | $671K |
| Dovato Dolutegravir Sodium/Lamivudine | 152 | 152 | 25 | $437K |
| Rosuvastatin Calcium Generic | 73 | 87 | 11 | $252 |
| Lisinopril Generic | 70 | 70 | Under 11 | $167 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 56 | 64 | Under 11 | $234K |
| Rukobia Fostemsavir Tromethamine | 45 | 45 | Under 11 | $397K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 44 | 44 | Under 11 | $171K |
| Ibuprofen Generic | 42 | 42 | Under 11 | $273 |
| Atorvastatin Calcium Generic | 41 | 45 | Under 11 | $133 |
| Levothyroxine Sodium Generic | 40 | 46 | Under 11 | $211 |
| Juluca Dolutegravir/Rilpivirine | 34 | 34 | Under 11 | $125K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 29 | 34 | 11 | $431 |
| Tivicay Dolutegravir Sodium | 24 | 26 | Under 11 | $70K |
| Descovy Emtricitabine/Tenofov Alafenam | 22 | 24 | Under 11 | $54K |
| Gabapentin Generic | 19 | 21 | Under 11 | $127 |
Brand drugs: 665 claims; generic drugs: 640 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jhoana P Quezada $755 ($755 in general payments such as food, travel and fees) from 5 companies. The largest payer was Gilead Sciences, Inc. with $335.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.